A new review in Engineering reveals that CRISPR technologies are revolutionizing regenerative medicine. Scientists from ...
ERS Genomics ('ERS'), which was established to provide broad access to the foundational CRISPR/Cas9 intellectual property ...
The global Stem Cell Assays Market is experiencing unprecedented growth, driven by advancements in regenerative medicine, ...
A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR technologies in the field of ...
Anna Molofsky, MD, PhD (left), and Martin Kampmann, PhD (right), are the 2025 recipients of the Bowes Biomedical Investigator ...
Potatoes are being gene-edited to resist fungi in the warm, wet Peruvian Andes. Sorghum is being taught to resist parasitic ...
Dosed first patient in global Phase 3 HAELO study evaluating NTLA-2002 for hereditary angioedema (HAE)Expect to complete enrollment of the HAELO ...
Mayo Clinic's Precision Mouse Engineering Core in Minnesota produces CRISPR/Cas9-mediated knockout and point mutant mice for researchers.
Intellia Therapeutics’ stock faces risks from market uncertainty and funding needs. Read why NTLA stock is downgraded to HOLD ...
Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results